menu search

Genentech's anti-amyloid beta antibody gantenerumab granted fda breakthrough therapy designation in alzheimer's disease

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that gantenerumab, ...

October 8, 2021, 4:48 pm

Roche's alzheimer's candidate secures fda breakthrough designation

Roche Holdings AG's (OTC: RHHBY) gantenerumab antibody received breakthrough therapy designation from...

October 8, 2021, 3:37 pm

Roche's alzheimer's candidate secures fda breakthrough designation

Roche Holdings AG's (OTC: RHHBY) gantenerumab antibody received breakthrough therapy designation from...

October 8, 2021, 3:37 pm

Roche's alzheimer's candidate secures fda breakthrough designation

Roche Holdings AG's (OTC: RHHBY) gantenerumab antibody received breakthrough therapy designation from...

October 8, 2021, 3:37 pm

Ad hoc announcement pursuant to art. 53 lr: genentech's anti-amyloid beta antibody gantenerumab granted fda breakthrough therapy designation in alzheimer's disease

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that gantenerumab, ...

October 8, 2021, 11:40 am

Ad hoc announcement pursuant to art. 53 lr: genentech's anti-amyloid beta antibody gantenerumab granted fda breakthrough therapy designation in alzheimer's disease

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that gantenerumab, ...

October 8, 2021, 11:40 am

Ad hoc announcement pursuant to art. 53 lr: genentech's anti-amyloid beta antibody gantenerumab granted fda breakthrough therapy designation in alzheimer's disease

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that gantenerumab, ...

October 8, 2021, 11:40 am

Why did chemocentryx shares soar 70% on friday premarket?

The FDA has approved ChemoCentryx Inc's (NASDAQ: CCXI) Tavneos (avacopan) as an adjunctive treatment for anti-neutrophil cytoplasmic autoantibody-a...

October 8, 2021, 8:02 am

Why did chemocentryx shares soar 70% on friday premarket?

The FDA has approved ChemoCentryx Inc's (NASDAQ: CCXI) Tavneos (avacopan) as an adjunctive treatment for anti-neutrophil cytoplasmic autoantibody-a...

October 8, 2021, 8:02 am

Why did chemocentryx shares soar 70% on friday premarket?

The FDA has approved ChemoCentryx Inc's (NASDAQ: CCXI) Tavneos (avacopan) as an adjunctive treatment for anti-neutrophil cytoplasmic autoantibody-a...

October 8, 2021, 8:02 am

Talem therapeutics announces multi-target antibody discovery research collaboration with pierre fabre

VICTORIA, British Columbia & CASTRES, France--(BUSINESS WIRE)---- $IPA #Deltavariant--IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (...

October 7, 2021, 8:38 am

Talem therapeutics announces multi-target antibody discovery research collaboration with pierre fabre

VICTORIA, British Columbia & CASTRES, France--(BUSINESS WIRE)---- $IPA #Deltavariant--IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (...

October 7, 2021, 8:38 am

Talem therapeutics announces multi-target antibody discovery research collaboration with pierre fabre

VICTORIA, British Columbia & CASTRES, France--(BUSINESS WIRE)---- $IPA #Deltavariant--IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (...

October 7, 2021, 8:38 am

Astrazeneca seeks eua from fda for long-acting antibody, nih director francis collins to step down

Yahoo Finance's Anjalee Khemlani reports on Astrazeneca seeking emergency use approval from the FDA for its long-acting antibody. Johnson & Johnson is...

October 5, 2021, 6:49 pm

Astrazeneca seeks eua from fda for long-acting antibody, nih director francis collins to step down

Yahoo Finance's Anjalee Khemlani reports on Astrazeneca seeking emergency use approval from the FDA for its long-acting antibody. Johnson & Johnson is...

October 5, 2021, 6:49 pm

Astrazeneca seeks eua from fda for long-acting antibody, nih director francis collins to step down

Yahoo Finance's Anjalee Khemlani reports on Astrazeneca seeking emergency use approval from the FDA for its long-acting antibody. Johnson & Johnson is...

October 5, 2021, 6:49 pm

Astrazeneca seeks eua from fda for long-acting antibody, nih director francis collins to step down

Yahoo Finance's Anjalee Khemlani reports on Astrazeneca seeking emergency use approval from the FDA for its long-acting antibody. Johnson & Johnson is...

October 5, 2021, 6:49 pm

Astrazeneca seeks eua from fda for long-acting antibody, nih director francis collins to step down

Yahoo Finance's Anjalee Khemlani reports on Astrazeneca seeking emergency use approval from the FDA for its long-acting antibody. Johnson & Johnson is...

October 5, 2021, 6:49 pm

Astrazeneca seeks emergency use authorisation for covid-19 antibody drug in us

AstraZeneca PLC has requested authorisation in the US for emergency use of its new antibody combination...

October 5, 2021, 4:31 am

Astrazeneca seeks emergency use authorisation for covid-19 antibody drug in us

AstraZeneca PLC has requested authorisation in the US for emergency use of its new antibody combination...

October 5, 2021, 4:31 am


Search within

Pages Search Results: